HCP
CNMD icon

Hexagon Capital Partners’s CONMED CNMD Stock Holding History

Hexagon Capital Partners’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17
Closed -$1.03K – 388
2025
Q1 		$1.03K Hold
17
– – ﹤0.01% 1544
2024
Q4 		$1.16K Hold
17
– – ﹤0.01% 1533
2024
Q3 		$1.22K Hold
17
– – ﹤0.01% 1306
2024
Q2 		$1.18K Sell
17
-11
-39% -$802 ﹤0.01% 1243
2024
Q1 		$2.24K Sell
28
-10
-26% -$891 ﹤0.01% 1145
2023
Q4 		$4.16K Sell
38
-4
-10% -$414 ﹤0.01% 1004
2023
Q3 		$4.24K Sell
42
-5
-11% -$575 ﹤0.01% 941
2023
Q2 		$6.39K Sell
47
-1
-2% -$122 ﹤0.01% 846
2023
Q1 		$4.99K Sell
48
-3
-6% -$290 ﹤0.01% 890
2022
Q4 		$4.52K Sell
51
-28
-35% -$2.32K ﹤0.01% 936
2022
Q3 		$6K Buy
+79
New +$7.45K ﹤0.01% 883

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Hexagon Capital Partners's CNMD Position: Q2 2025 in Review

Hexagon Capital Partners sold out of CONMED (CNMD) in Q2 2025, closing a stake of 17 shares — an estimated $1.03K sold.

Hexagon Capital Partners first reported a position in CNMD in Q3 2022 and held it in 11 quarters. The position peaked at $6.39K in Q2 2023. 276 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

  • Hexagon Capital Partners reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 17 CONMED shares in Q2 2025, an estimated $1.03K.
  • Hexagon Capital Partners first reported a position in CONMED in Q3 2022 and held it in 11 quarters.
  • Hexagon Capital Partners's CONMED position peaked at $6.39K in Q2 2023.
  • 276 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.